Fibroadenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fibroadenoma}} | {{Fibroadenoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{IO}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the secondary prevention of fibroadenoma. | There are no established measures for the [[secondary prevention]] of fibroadenoma. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the | There are no established measures for the [[secondary prevention]] of fibroadenoma. | ||
==References== | ==References== | ||
Latest revision as of 15:37, 15 October 2019
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma secondary prevention |
|
Risk calculators and risk factors for Fibroadenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2]
Overview
There are no established measures for the secondary prevention of fibroadenoma.
Secondary Prevention
There are no established measures for the secondary prevention of fibroadenoma.